Türkçe
In stage 3 breast cancer, the five-year survival rate is between 66–72%. At this stage, the cancer has spread beyond the breast tissue and usually to the surrounding lymph nodes. With early and effective treatment, the disease can be brought under control and long-term survival can be achieved.
Symptoms of stage 3 breast cancer may include a large mass in the breast, significant enlargement of the axillary lymph nodes, skin retraction, color changes, or nipple deformity. These findings indicate that the disease has progressed and require immediate evaluation.
The treatment process is multidisciplinary and usually begins with neoadjuvant (preoperative) chemotherapy. This is followed by surgery and radiotherapy. Depending on hormone receptor status and HER2 positivity, hormone therapy or targeted treatments are also integrated into the treatment.
Life expectancy may vary depending on factors such as the biological subtype of the tumor, the patient’s response to treatment, and general health status. After the intensive treatment process, regular follow-up and supportive care play an important role in reducing the risk of recurrence.
What Does Stage 3 Breast Cancer Mean?
Breast cancer staging is performed according to the extent of the disease in the breast and its effect on surrounding tissues. Stage three is generally defined as locally advanced breast cancer. At this stage, the tumor may have reached a larger size in the breast or spread to the axillary lymph nodes. In some patients, involvement of the breast skin or chest wall may also accompany the condition.
This stage is divided into the subgroups 3A, 3B, and 3C. This subclassification is made according to the size of the tumor, lymph node involvement, and its relationship with surrounding tissues. Therefore, each patient’s condition may show different characteristics.
How Is Life Expectancy Evaluated in Stage 3 Breast Cancer?
Although the expression “life expectancy” is often perceived by patients as a definite time estimate, this issue is much more variable in medicine. Life expectancy in stage 3 breast cancer may vary according to;
- The biological characteristics of the tumor,
- Hormone receptor status,
- HER2 status,
- The patient’s general health condition,
- The response to the treatments applied
Statistical data are based on the past outcomes of large patient groups and do not provide a definite prediction for an individual patient. Therefore, numerical information should be evaluated not as a personal expectation but as a general framework. Today, with the development of treatment options, many patients diagnosed with stage 3 breast cancer can continue their lives under long-term follow-up.
What Are the Symptoms of Stage 3 Breast Cancer?
The symptoms seen at this stage may vary depending on the progression of the disease in the breast and surrounding tissues. Some patients may experience noticeable complaints at an early stage, while others may notice the symptoms later.
Frequently reported symptoms include:
- A hard palpable mass in the breast or enlargement of the mass
- Redness, thickening, or an orange peel appearance of the breast skin
- Inward retraction or change in shape of the nipple
- Nipple discharge
- Palpable swelling or tenderness in the armpit
- Pain or a feeling of fullness in the breast
These symptoms do not always mean breast cancer. However, specialist evaluation is important in changes that persist for a long time or gradually increase.
How Does the Diagnostic Process Proceed?
The diagnosis of stage 3 breast cancer usually begins with a clinical examination and imaging methods. Mammography, ultrasound, and magnetic resonance imaging (MRI) are frequently used. A biopsy is performed to confirm the diagnosis, and the sample obtained is examined pathologically.
Pathology results provide information about the type and biological characteristics of the tumor. This information plays a decisive role in treatment planning. The diagnostic process may be physically and emotionally challenging for patients. At this stage, asking questions and trying to understand the process is a natural need.
Treatment Methods for Stage 3 Breast Cancer
The treatment plan is generally created with a multidisciplinary approach. Specialists in surgery, medical oncology, and radiation oncology evaluate the patient together.
Chemotherapy
In stage 3, chemotherapy is frequently administered before surgery (neoadjuvant). The aim is to shrink the tumor and make it suitable for surgery. In some patients, chemotherapy may also be planned after surgery. The duration of chemotherapy and drug combinations vary from person to person.
Surgical Treatment
Breast surgery is considered after chemotherapy. While breast-conserving surgery may be possible in some patients, mastectomy may be preferred in certain cases. The surgical decision is made by considering the extent of the tumor and the patient’s general condition.
Radiotherapy
Radiotherapy aims to bring any remaining cancer cells under control after surgery. It has an important role especially in patients with lymph node involvement. The treatment plan is determined individually according to the areas to be irradiated.
Hormone and Targeted Therapies
In hormone receptor-positive patients, hormone therapies may be planned for the long term. In HER2-positive patients, targeted smart drugs may be added to the treatment. These treatments are selected according to the characteristics of the cancer cells.
What Patients Experience During the Treatment Process
The treatment of stage 3 breast cancer is a long-term process. During this period, patients may experience side effects such as fatigue, nausea, hair loss, or skin sensitivity. However, each patient’s experience is different; while some people go through treatment more mildly, others may feel more intense effects.
Psychological support is at least as important as physical treatment during this process. Helping patients not feel alone can make the process more manageable.
Why Are Follow-Up and Check-Ups Important?
After treatment is completed, regular check-ups are of great importance. These check-ups are performed both to monitor the course of the disease and to detect possible side effects early. The frequency and content of follow-up are planned according to the patient’s condition.
Prof. Dr. Ebru Ayvazoğlu Soy is a physician known for her academic background and surgical experience in the field of general surgery. After graduating from TED Ankara College in 1998, she completed her medical education at Hacettepe University Faculty of Medicine in 2005. She completed her residency training in the Department of General Surgery at Başkent University Faculty of Medicine in 2012, obtained the title of Associate Professor in 2019, and became a Professor in 2024. She currently serves as a faculty member in the Department of General Surgery at Ankara Medipol University Faculty of Medicine. With nearly 100 publications in international indexed journals and numerous scientific presentations, Prof. Dr. Ayvazoğlu Soy is a member of the International College of Surgeons, The Transplantation Society, Turkish Surgical Association and the Ankara Surgical Association. In addition to her academic position at Ankara Medipol University, she also sees patients in her private clinic in Çankaya, specializing in general surgery, breast surgery, and endocrine surgery.
